Anthony Martinelli

Anthony Martinelli is founder and Editor-in-Chief of The Marijuana Herald. Anthony previously served as Editor-in-Chief of TheJointBlog.com (a cannabis news site he founded in 2011 and sold in 2019), and he has worked as a campaign manager and communications director for multiple political campaigns and elected officials. Anthony can be reached at Info@TheMarijuanaHerald.com.

Author's posts

Nova Scotia Marijuana Sales Reach Record High in July, Bringing Year-to-Date Total to CA$75 Million

Nova Scotia set a new monthly record for marijuana sales in July, generating CA$12.045 million in revenue. The figure surpasses all previous monthly totals since legalization in 2018, bringing Nova Scotia’s year-to-date sales to CA$75.773 million and highlighting consistent growth in the province’s regulated market.

Continue reading

President Trump’s Decision to Reschedule Marijuana Followed Months of White House Debate and Dozens of Meetings

President Trump’s decision to move forward with rescheduling marijuana followed months of internal debate at the White House, led most prominently by Susie Wiles and Stephen Miller, according to a senior advisor to the president. According to the advisor, Miller quickly emerged as one of the most prominent opponents of rescheduling, while Wiles strongly pushed …

Continue reading

Medical Cannabis on UK’s National Health Service Could Generate £13.3 Billion Over a Decade and Help Thousands Return to Work

Expanding access to medical cannabis through the United Kingdom’s National Health Service (NHS) would generate up to £13.3 billion over the next decade while giving thousands of people with chronic illnesses the chance to return to the workforce, according to a new analysis. The analysis from the Centre for Economics and Business Research and Curaleaf …

Continue reading

Study: CBD Alters Gene Expression and Promotes Apoptosis in Chronic Myeloid Leukemia Cells

A study published in Global Medical Genetics by researchers at the Stephan Angeloff Institute of Microbiology has found that cannabidiol (CBD) produces wide-ranging genetic and molecular effects in chronic myeloid leukemia (CML) cells, suggesting therapeutic potential for resistant cases of the disease. CML, a blood cancer characterized by the Philadelphia chromosome and the BCR-ABL1 fusion …

Continue reading

Study: Subcritical Water Extraction Offers Sustainable Alternative for Cannabinoid Recovery

A new study published in Global Medical Genetics by researchers at the University of Ljubljana has identified subcritical water extraction (SWE) as a promising and environmentally friendly method for obtaining hemp extracts rich in antioxidants. The research evaluated SWE alongside conventional and modern extraction techniques, including Soxhlet ethanol extraction, high-pressure ethanol extraction, and supercritical CO₂ …

Continue reading

Massachusetts: Psilocybin Legalization Bill Set for September 29 Public Hearing

Massachusetts lawmakers will soon consider two separate proposals that would expand access to psilocybin, with both scheduled for public hearings on September 29. The first measure, House Bill 4050, was introduced by State Representative Patrick Kearney (D) in April and would remove psilocybin and psilocyn from the state’s list of controlled substances. Those 21 and …

Continue reading

Long-Term Study Finds CBD Reduces Seizures and Improves Daily Functioning in Children With Drug-Resistant Epilepsy

A large real-world study has found that cannabidiol (CBD), including off-label use, can significantly reduce seizures and improve daily functioning in children with drug-resistant epilepsy, with benefits persisting for more than a year. The prospective trial, published in the European Journal of Neurology, followed 103 pediatric patients treated at a tertiary center over a two-year period. …

Continue reading

GOP Rep. Dan Newhouse (WA) Signs On as Newest Sponsor of STATES 2.0 Act, Which Would End Federal Marijuana Prohibition in Legal States

Congressmember Dan Newhouse, a Republican from Washington State, has joined as the newest cosponsor of the STATES 2.0 Act, bringing the total number of House sponsors to seven. The STATES 2.0 Act, reintroduced earlier this year by Representatives Dave Joyce (R-OH), Max Miller (R-OH) and Dina Titus (D-NV), would effectively end federal marijuana prohibition in …

Continue reading

Study: Chlorophyll Compounds Boost CBD Bioavailability and Therapeutic Effects

Researchers publishing in the International Journal of Pharmaceutics have found that chlorophyll derivatives, particularly pheophytins, play a significant role in boosting the effectiveness of cannabidiol (CBD). The study suggests that these natural compounds act as bioenhancers, improving the solubility, absorption, and therapeutic outcomes of CBD.

Continue reading

Canada Cannabis Sales Reach CA$485 Million in July, Third-Highest Since Legalization, Year-to-Date Now at CA$3.12 Billion

Canada’s legal cannabis industry generated CA$485 million in sales during July, according to newly released figures from Statistics Canada. That makes July the third-highest monthly total since nationwide legalization in 2018, following December 2023 and August 2024. The new figures bring year-to-date sales for 2025 to CA$3.12 billion, reflecting steady growth in consumer demand through …

Continue reading